DETERMINATION OF AN APPROPRIATE DOSE RATIO OF A SYNERGISTIC COMBINATION OF LONG-ACTING BRONCHODILATORS FOR THE MAINTENANCE TREATMENT OF ASTHMA AND COPD

被引：0
|
作者：
Menchi, Elena [1 ]
El Khattabi, Charaf [2 ]
Denis, Olivier [3 ]
Pochet, Stephanie [2 ]
Amighi, Karim [1 ]
Wauthoz, Nathalie [1 ]
机构：
[1] Univ Libre Bruxelles ULB, Lab Pharmaceut & Biopharmaceut, Fac Pharm, Blvd Triomphe, B-1050 Brussels, Belgium
[2] Univ Libre Bruxelles ULB, Pharmacol Pharmacotherapy & Pharmaceut Care, Fac Pharm, Blvd Triomphe, B-1050 Brussels, Belgium
[3] Sciensano, Immune Response, Rue Engeland 642, B-1180 Brussels, Belgium
来源：
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY | 2022年 / 35卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
29
引用
收藏
页码：A11 / A11
页数：1
相关论文
共 50 条
  • [31] Long-Acting Bronchodilators in Severe COPD: Kinematic Effects on Chest Wall
    Dal Negro, R. W.
    Menegoni, F.
    Micheletto, C.
    Turati, C.
    Turco, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [32] Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use
    Decramer, Marc
    Dahl, Ronald
    Kornmann, Oliver
    Korn, Stephanie
    Lawrence, David
    McBryan, Danny
    RESPIRATORY MEDICINE, 2013, 107 (02) : 223 - 232
  • [33] Real-Life COPD Outpatient Treatment With Long-Acting Bronchodilators In Germany: The Daccord Registry
    Kardos, P.
    Buhl, R.
    Criee, C. -P.
    Vogelmeier, C.
    Worth, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [34] The DACCORD study: Real-life COPD outpatient treatment with long-acting bronchodilators in Germany
    Worth, Heinrich
    Buhl, Roland
    Criee, Carl-Peter
    Kardos, Peter
    Vogelmeier, Claus
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [35] Cost-effectiveness analysis of long-acting bronchodilators for the treatment of COPD (moderate to very severe)
    Ravasio, Roberto
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2015, 2 (03) : 143 - 151
  • [36] Combination therapy with a long-acting β2-agonist and an inhaled corticosteroid as initial maintenance treatment in asthma
    Lee, DKC
    Currie, GP
    Lipworth, BJ
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 94 (03) : 410 - 411
  • [37] Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β2-agonist bronchodilators
    Skolnik, Neil S.
    Nguyen, Trang Susan
    Shrestha, Aarisha
    Ray, Riju
    Corbridge, Thomas C.
    Brunton, Stephen A.
    POSTGRADUATE MEDICINE, 2020, 132 (02) : 198 - 205
  • [38] Long-acting bronchodilators improve Health Related Quality of Life in patients with COPD
    Braido, Fulvio
    Baiardini, Ilaria
    Cazzola, Mario
    Brusselle, Guy
    Marugo, Fiorenza
    Canonica, Giorgio Walter
    RESPIRATORY MEDICINE, 2013, 107 (10) : 1465 - 1480
  • [39] Use Patterns of Long-acting Bronchodilators in Routine COPD Care: The OUTPUL Study
    Di Martino, Mirko
    Agabiti, Nera
    Bauleo, Lisa
    Kirchmayer, Ursula
    Cascini, Silvia
    Pistelli, Riccardo
    Colamesta, Vittoria
    Patorno, Elisabetta
    Pinnarelli, Luigi
    Fusco, Danilo
    Perucci, Carlo Alberto
    Davoli, Marina
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 11 (04) : 414 - 423
  • [40] Differential pharmacology and clinical utility of long-acting bronchodilators in COPD - focus on olodaterol
    Matera, Maria Gabriella
    Ora, Josuel
    Cazzola, Mario
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1805 - 1811
12345